YK Bioventures Opportunities GP I, LLC - Dec 11, 2024 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
10%+ Owner
Signature
YK Bioventures Opportunities GP I, LLC, By /s/ Gary K. Yeung, Managing Partner
Stock symbol
CERO
Transactions as of
Dec 11, 2024
Transactions value $
-$400,456
Form type
4
Date filed
12/13/2024, 06:41 PM
Previous filing
Dec 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERO Common Stock Sale -$108K -1.34M -7.09% $0.08 17.6M Dec 11, 2024 By YK Bioventures Opportunities Fund I, L.P. F1
transaction CERO Common Stock Sale -$113K -1.61M -9.16% $0.07 16M Dec 12, 2024 By YK Bioventures Opportunities Fund I, L.P. F1
transaction CERO Common Stock Sale -$180K -3M -18.74% $0.06 13M Dec 13, 2024 By YK Bioventures Opportunities Fund I, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

YK Bioventures Opportunities GP I, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Securities are held directly by YK Bioventures Opportunities Fund I, L.P. (f/k/a YK Bioventures, LLC) ("YK Opps I"). YK Bioventures Opportunities GP I, LLC ("YK Opps I GP") is the general partner of YK Opps I and may be deemed to beneficially own the shares held by YK Opps I. Mitchell W. Kossar and Gary K. Yeung are managing partners of YK Opps I GP, and may be deemed to share voting and investment power over the shares held by YK Opps I. Each of YK Opps I GP and Messrs. Kossar and Yeung disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.